Takeda Pharmaceutical Co Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 13.49 M | $210.26 M | 0.62% | 0.43% |
| MORGAN STANLEY | 02/13/2026 | 6.37 M | $99.36 M | -17.13% | 0.20% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 5.68 M | $88.60 M | 100.89% | 0.18% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 4.80 M | $74.90 M | -3.00% | 0.15% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 4.29 M | $66.94 M | 1,426.43% | 0.14% |
| UBS GROUP AG | 01/29/2026 | 4.12 M | $64.29 M | -30.04% | 0.13% |
| FMR LLC | 02/17/2026 | 4.06 M | $63.25 M | -3.11% | 0.13% |
| BRANDES INVESTMENT PARTNERS, LP | 02/11/2026 | 3.88 M | $60.52 M | -1.27% | 0.12% |
| BLACKROCK, INC. | 02/12/2026 | 2.73 M | $42.59 M | -17.41% | 0.09% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.62 M | $40.82 M | -32.25% | 0.08% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 2.38 M | $37.15 M | -5.36% | 0.08% |
| VAN ECK ASSOCIATES CORP | 02/13/2026 | 2.31 M | $35.94 M | 98.35% | 0.07% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.70 M | $26.49 M | -6.84% | 0.05% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.57 M | $24.55 M | -2.10% | 0.05% |
| MANAGED ASSET PORTFOLIOS, LLC | 01/29/2026 | 1.50 M | $23.32 M | 0.63% | 0.05% |
| QUANTINNO CAPITAL MANAGEMENT LP | 02/17/2026 | 1.07 M | $16.67 M | 9.80% | 0.03% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1.06 M | $16.53 M | 2.53% | 0.03% |
| ENVESTNET ASSET MANAGEMENT INC | 02/10/2026 | 1.02 M | $15.91 M | 17.77% | 0.03% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 962.50 K | $15.01 M | 1,070.74% | 0.03% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 890.09 K | $13.88 M | -65.18% | 0.03% |
| TORONTO DOMINION BANK | 02/17/2026 | 823.20 K | $12.83 M | -72.60% | 0.03% |
| CROSSMARK GLOBAL HOLDINGS, INC. | 02/03/2026 | 745.18 K | $11.62 M | 2.47% | 0.02% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 679.28 K | $10.59 M | -11.35% | 0.02% |
| COLONY GROUP, LLC | 02/13/2026 | 562.05 K | $8.76 M | 458.75% | 0.02% |
| STIFEL FINANCIAL CORP | 02/13/2026 | 554.29 K | $8.64 M | 8.91% | 0.02% |
| ROYAL BANK OF CANADA | 02/17/2026 | 554.13 K | $8.64 M | 13.23% | 0.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 413.69 K | $6.45 M | 7.24% | 0.01% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 408.60 K | $6.37 M | 2.41% | 0.01% |
| CREATIVE PLANNING | 02/17/2026 | 395.39 K | $6.16 M | -14.68% | 0.01% |
| CITADEL ADVISORS LLC | 02/17/2026 | 389.73 K | $6.08 M | 415.36% | 0.01% |
| FEDERATED HERMES, INC. | 02/12/2026 | 376.86 K | $5.88 M | -5.40% | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 376.20 K | $5.86 M | 2,750.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 362.87 K | $5.66 M | -1.49% | 0.01% |
| BLEAKLEY FINANCIAL GROUP, LLC | 02/09/2026 | 362.76 K | $5.66 M | 0.12% | 0.01% |
| LPL FINANCIAL LLC | 02/11/2026 | 356.43 K | $5.56 M | 41.34% | 0.01% |
| ETHIC INC. | 02/03/2026 | 304.66 K | $4.75 M | -1.96% | 0.01% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 298.40 K | $4.65 M | 44.02% | 0.01% |
| QRG CAPITAL MANAGEMENT, INC. | 02/02/2026 | 288.73 K | $4.50 M | 2.70% | 0.01% |
| CLEAN YIELD GROUP | 01/26/2026 | 260.80 K | $4.07 M | -1.97% | 0.01% |
| HANTZ FINANCIAL SERVICES, INC. | 02/09/2026 | 253.48 K | $3.95 M | -2.57% | 0.01% |
| JPMORGAN CHASE & CO | 02/11/2026 | 242.18 K | $3.78 M | -2.16% | 0.01% |
| NATIXIS ADVISORS, L.P. | 02/10/2026 | 227.75 K | $3.55 M | -52.59% | 0.01% |
| US BANCORP \DE\ | 01/30/2026 | 217.53 K | $3.39 M | 83.22% | 0.01% |
| PATHSTONE HOLDINGS, LLC | 02/13/2026 | 216.38 K | $3.37 M | -9.21% | 0.01% |
| MANNING & NAPIER ADVISORS LLC | 02/03/2026 | 215.73 K | $3.37 M | -4.73% | 0.01% |
| CETERA INVESTMENT ADVISERS | 02/17/2026 | 208.92 K | $3.26 M | -2.01% | 0.01% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 197.51 K | $3.08 M | -88.88% | 0.01% |
| CATALYST CAPITAL ADVISORS LLC | 02/10/2026 | 192.00 K | $2.99 M | 3.78% | 0.01% |
| SEI INVESTMENTS CO | 02/13/2026 | 191.20 K | $2.98 M | -1.08% | 0.01% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 02/06/2026 | 189.57 K | $2.96 M | 100.00% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Takeda Pharmaceutical Co institutional Ownership - FAQ's
During the previous two years, 487 institutional investors and hedge funds held shares of Takeda Pharmaceutical Co. The most heavily invested institutionals were:
Capital Research Global Investors: 13.49 M
MORGAN STANLEY: 6.37 M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 5.68 M
GOLDMAN SACHS GROUP INC: 4.8 M
D. E. Shaw & Co., Inc.: 4.29 M
UBS Group AG: 4.12 M
2.65% of Takeda Pharmaceutical Co stock is owned by institutional investors.
Institutional investors have bought a total of 103.08 M shares in the last 24 months. This purchase volume represents approximately $1.80 B in transactions.